Allal Boutajangout

Immunotherapy Targeting Pathological Tau Conformers in a Tangle Mouse Model Reduces Brain Pathology with Associated Functional Improvements

Ayodeji A. Asuni, Allal Boutajangout, David Quartermain et al. · Journal of Neuroscience · 2007 · 506 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies

M. Rejwan Ali, Mostafa Sadoqi, Simon Geir Møller et al. · Journal of Molecular Graphics and Modelling · 2017 · 34 citations

Pharmacy, Medicinal Chemistry, Pharmacology +14

Affibody-Mediated Sequestration of Amyloid β Demonstrates Preventive Efficacy in a Transgenic Alzheimer’s Disease Mouse Model

Allal Boutajangout, Hanna Lindberg, Abdulaziz Awwad et al. · Frontiers in Aging Neuroscience · 2019 · 26 citations · Full text

Pharmacy, Neuroscience, Pharmacology +17

High performance of a novel point-of-care blood test for <i>Toxoplasma</i> infection in women from diverse regions of Morocco

Bouchra El Mansouri, Fatima Amarir, François Peyron et al. · Emerging Microbes & Infections · 2021 · 17 citations · Full text

Veterinary Medicine, Infectious Diseases, Public Health Practice +16

P3‐427: Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy

Allal Boutajangout, Johanna Ingadottir, Peter Davies et al. · Alzheimer s & Dementia · 2010 · 15 citations

Life Sciences, Neurology, Neuroscience +16